450 likes | 464 Views
Learn about the identification and management of women at high risk for hereditary breast and ovarian cancer. Discover the options available for high-risk individuals, including chemoprevention, prophylactic oophorectomy, and screening. Find out how risk assessment tools and clinical decision support systems can improve patient care.
E N D
Identification and Management of Women at High Risk for Hereditary Breast and Ovarian Cancer Kevin S.Hughes, MD, FACS Co-Director, Avon Comprehensive Breast Evaluation Center Massachusetts General Hospital Surgeon The Newton-Wellesley Hospital Breast Center
DISCLOSURESHughesRiskApps.NetOpen Access Solutionhttp://www.HughesRiskApps.comSpeaker’s BureauMyriad Geneticskshughes@partners.org
Cancer Risk BRCA1BRCA2 F e m a l e M a l e Breast 50-87% 50-87% Ovary 40-60% 10-20% Breast 6%
CANCER SPORADIC HEREDITARY CANCER Hereditary vs Sporadic Cancer Knudson’s 2 hit hypothesis
Family history Multiple relatives affected Young age at diagnosis Multiple primary cancers Male breast cancer
Options for high risk Chemoprevention Prophylactic Oophorectomy Screening
Breast cancer with and without RRSO (+/-HRT) Adjusted for age at start of follow up and stratified by center
BRCA1/2 Mutation carriers in the US ~1,000,000 BRCA1/2 carriers
BRCA1/2 Mutation carriers in the USFemales 20 and above between 1996 and today Close to 500,000 BRCA1/2 carriers
16 years of genetic testing: BRCA1/2 carriers found to date • ~60,000 (12%) of the ~500,000 carriers BUT Most people tested already have cancer Estimate that 95% of unafffected carriers remain unidentified
Mammography in the 1970’s Patient presents with obvious cancer
Mammography in the 1970’s Patient presents with obvious cancer Mammogram shows obvious cancer Minimal impact on population health
Mammography today Millions of screening mammograms Tens of thousands of subclinical cancers identified Major impact on population health
Risk identification today Age 35 presents with obvious cancer
Risk identification today Age 35 presents with obvious cancer Pedigree shows obvious hereditary syndrome Minimal impact on population health
Risk Assessment Tomorrow Millions of family histories collected and assessed Hundreds of thousands of high risk patients identified Tens of thousands of cancers prevented or found earlier Major impact on population health
Find all mutation carriers Family history & selective testing Population based genetic testing Adult syndromes Newborn screening
Memory-Based Medicine “Current medical practice relies heavily on the unaided mind to recall a great amount of detailed knowledge” Crane, Raymond, The Permanente Journal 7:62, 2003
Know models or use a computer BRCAPRO: Bayes-Mendel Model
Clinician synthesizes patient data, compares to guidelines/models, determines next steps Personal History Family History Ethnicity Genetic Testing Who is at risk
Patient completes paper form Reviews data using memory of guidelines Orders Genetic Testing Currently: Paper + memory
EHR: Paper + extra work + memory Patient completes paper form Staff enters data into the EHR Reviews data using guidelines and algorithms Orders Genetic Testing
Clinical Decision Support (CDS) Apply Algorithms/Guidelines to patient data Identify best course of action Results displayed as intuitive Visualizations BRCAPRO Mutation Risk 25% Suggest Genetic Testing Facilitates best action as part of workflow
HughesRiskApps.Net Patient enters data into Tablet PC or iPad Patient educational materials Clinical Decision Support Flag for risk assessment
Newton Wellesley HospitalSince 4/2007 • Over 50,000 unique patients • 2255 (4.5%) mutation risk 10% or greater
Mammography patients needing risk assessment Not Jewish No Cancer Jewish No Cancer Not Jewish Cancer Jewish Cancer
DISCLOSURESHughesRiskApps.NetOpen Access Solutionhttp://www.HughesRiskApps.comkshughes@partners.org
Average EHR today Click open 4 screens